Rare diseases, an emerging global public health priority, require an evidence-based
estimate of the global point prevalence to inform public policy. We used the publicly available …

The Human Phenotype Ontology (HPO, https://hpo.jax.org ) was launched in 2008 to provide
a comprehensive logical standard to describe and computationally analyze phenotypic …

Deep phenotyping has been defined as the precise and comprehensive analysis of phenotypic
abnormalities in which the individual components of the phenotype are observed and …

The Human Phenotype Ontology (HPO)—a standardized vocabulary of phenotypic
abnormalities associated with 7000+ diseases—is used by thousands of researchers, clinicians, …

Rare disorders are scarcely represented in international classifications and therefore
invisible in information systems. One of the major needs in health information systems and for …

Provision of a molecularly confirmed diagnosis in a timely manner for children and adults with
rare genetic diseases shortens their "diagnostic odyssey," improves disease management, …

A lack of robust knowledge of the number of rare diseases and the number of people affected
by them limits the development of approaches to ameliorate the substantial cumulative …

The International Rare Diseases Research Consortium (IRDiRC) was founded in 2011 with
the conviction that rare diseases research had reached a critical juncture. Proof of principle …

Clinical practice guidelines (CPGs) for rare diseases (RDs) are scarce, may be difficult to
identify through Internet searches and may vary in quality depending on the source and …

Rare diseases by definition are conditions that affect small numbers of people. The
prevalence threshold that designates a disease as rare varies in different countries. Generally, …